Ref ID: 17739
Author:
M.L. Moretti, P. Trabasso, L. Lyra, R. Fagnani, M.R. Resende,
L.F. Bachur, L.G.O. Cardoso*, A.Z. Schreiber
Author address:
Campinas, BR)
Full conference title:
22nd European Congress of Clinical Microbiology and Infectious Diseases
Abstract:
Objective: To determine the epidemiology of Candida bloodstream
infection in a 5-year surveillance.
Methods: From 2006 to 2010, a retrospective study was conducted in
a university referral tertiary care hospital to study the frequency and
distribution of Candida species in different medical specialties. The use
of mechanical ventilation, central venous catheter and urinary catheter
were recorded per 1000 patient-days and the use of antifungal was
calculated using defined daily dose (DDD).
Results: A total of 313 episodes were identified and the overall
incidence was 0.57 (0.43-0.71) episodes per 1000 patients-day. C.
albicans caused 44% of the overall episodes, followed by C. tropicalis
(21.7%), C. parapsilosis (14.4%), C. glabrata (11.2%) and C. krusei
(3.5%). The incidence of C. glabrata significantly increased from 2006
to 2010 (range: 4.3-23.5%) (p = 0.024) and C. parapsilosis decreased
(p = 0.046). C. glabrata was associated with malignancies (p = 0.004)
and C. krusei with hematologic malignancies (p < 0.0001). The use of
antifungal was higher in the hematology/bone marrow transplant units
and represented 40% of all fluconazole prescription in the hospital.
There was no correlation with the use of fluconazole and the increasing
ratio of C. glabrata (r = 0.60). The use of invasive devices was
significantly higher in the ICUs than the medical and surgical
emergencies units (p < 0.001). In contrast, the emergencies had
higher incidence of candidemia (2-2.1 episodes/1000 patients-day)
than the ICUs (1.6 episodes 1000 patients-day).
Conclusion: C. glabrata showed a significant raise differently from the
current national literature where C. parapsilosis remained the most
Abstract Number: P783
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a